Pralnacasan inhibits proinflammatory cytokines IL-18, IL-1beta , and IFN-gamma. Pralnacasan is an effective, non-peptide, and orally active interleukin-1beta converting enzyme inhibitor (Ki: 1.4 nM). Pralnacasan has the potential for osteoarthritis and rheumatoid arthritis treatment.
Molecular Weight:
523.54
CAS Number:
[192755-52-5]
Formula:
C26H29N5O7
Target:
Others|||Caspase
T16570
* VAT and and shipping costs not included. Errors and price changes excepted
